3 results
Approved WMOCompleted
The primary objective of this study is to determine whether the Impella cVAD device vs. IABP therapy leads to a higher 30 day survival rate in shock STEMI patients in the setting of primary PCI.
Approved WMOCompleted
To assess the bioequivalence of two marketed formulations of ribavirin (ribavirin solution and capsules).
Approved WMOCompleted
Study part 1A) To determine specificity and sensitivity of diagnosis of anterior ocular pathology with the smartphone enabled device, as compared to in-clinic slit-lamp and tonometry examination (gold standard).B) To determine ease of use of theā¦